Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel medicines to normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein for people with cystic fibrosis (CF). The company focuses on patients with CF who have mutations in the CFTR gene, aiming to improve their quality of life and clinical outcomes.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.